News and Events

De nouvelles opportunités majeures de croissance Paris, France et Camberley, Royaume-Uni – 27 juillet 2020 – Novacyt (ALTERNEXT : ALNOV ; AIM : NCYT), spécialiste mondial du diagnostic clinique, fait un état des lieux de ses activités R&D. http://novacyt.com/wp-content/uploads/2020/07/Novacyt-RD-Update-27-07-20-FRENCH.pdf

Significant new opportunities for growth Paris, France and Camberley, UK – 27 July 2020 – Novacyt (EURONEXT GROWTH:ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces an R&Dupdate. http://novacyt.com/wp-content/uploads/2020/07/Novacyt-RD-Update-27-07-20-ENGLISH.pdf

Sales growth of more than 900%, debt-free andsignificantly cashflow positiveDemand for COVID-19 test expected to continue into 2021 Paris, France and Camberley, UK – 13 July 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces an unaudited trading update for the six months ended 30 June 2020. http://novacyt.com/wp-content/uploads/2020/07/Novacyt-H1-2020-Trading-Update-13-07-2020-ENGLISH.pdf